Zepp Health (NYSE:ZEPP) Given a $13.87 Price Target by Fundamental Research Analysts

Zepp Health (NYSE:ZEPP) has been assigned a $13.87 target price by equities researchers at Fundamental Research in a research note issued to investors on Tuesday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Fundamental Research’s price target would indicate a potential upside of 348.87% from the company’s previous close.

Zepp Health Stock Performance

Shares of Zepp Health stock traded up $0.13 on Tuesday, hitting $3.09. The stock had a trading volume of 7,518 shares, compared to its average volume of 19,535. The company’s 50 day moving average price is $2.98 and its 200 day moving average price is $3.10. The stock has a market cap of $46.51 million, a price-to-earnings ratio of -1.24 and a beta of 0.75. Zepp Health has a 52-week low of $2.06 and a 52-week high of $4.38. The company has a current ratio of 1.21, a quick ratio of 0.87 and a debt-to-equity ratio of 0.13.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Zepp Health stock. Mandatum Life Insurance Co Ltd purchased a new stake in Zepp Health Co. (NYSE:ZEPP) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 10,750 shares of the company’s stock, valued at approximately $28,000. Mandatum Life Insurance Co Ltd owned 0.07% of Zepp Health at the end of the most recent reporting period. Hedge funds and other institutional investors own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.